首页|局部晚期宫颈癌采用新辅助介入化疗的临床治疗价值评价

局部晚期宫颈癌采用新辅助介入化疗的临床治疗价值评价

扫码查看
目的:本文主要探究局部晚期宫颈癌采用新辅助介入化疗的临床治疗价值评价。方法选取我院于2013年4月~2014年4月期间收治的局部晚期宫颈癌患者120例,将以上患者随机分为观察组(60例)和对照组(60例),对照组患者应用新辅助静脉化疗,观察组患者采用新辅助介入化疗,最后比较两组患者的近期疗效、远期疗效以及不良反应。结果经过治疗,两组患者的近期疗效均良好,差异不明显(P>0.05),不具有统计学意义,但是观察组患者在生存期方面要明显长于对照组患者,在手术率方面要高于对照组,均差异明显, P<0.05,具有统计学意义。结论使用新辅助介入化疗治疗局部晚期宫颈癌患者,其效果明显,能显著提高患者的生存质量,值得在临床上推广使用。
Objective: To evaluate the clinical value of this paper is mainly to explore the treatment of locally advanced cervical cancer with neoadjuvant chemotherapy. Methods:120 patients with locally advanced cervical cancer were selected in our hospital in 2013 April~2014 year in April during the above cases, the patients were randomly divided into observation group (60 cases) and control group (60 cases), the control group patients with neoadjuvant chemotherapy, the observation group were treated by intra- arterial neoadjuvant chemotherapy, long- term therapeutic effect of recent the curative effect, the last of two groups were compared and the adverse reaction. Results:after the treatment, the short- term curative effect of two groups of patients were good, the difference was not significant (P>0.05), was not statistically significant, but the observation group patients survival than the patients in the control group, the operation rate is higher than that of control group, were signifi-cantly different, P<0.05, with statistical significance. Conclusion:the use of neoadjuvant chemotherapy in treatment of patients with locally ad-vanced cervical cancer, its effect is obvious, can significantly improve the quality of life of patients, is worthy of promotion in clinical use.

马昭平

展开 >

成都大学附属医院妇产科,四川 成都 610081

局部晚期宫颈癌 新辅助介入化疗 治疗价值

2015

现代妇女(医学前沿)

现代妇女(医学前沿)

ISSN:
年,卷(期):2015.(1)
  • 2